US-listed company Processa is evaluating corporate cryptocurrency financial strategies
Foresight News reports that U.S. pharmaceutical company Processa (NASDAQ: PCSA) has announced a strategic investment, though the specific amount was not disclosed, and is currently evaluating a corporate cryptocurrency financial strategy. The company has engaged LifeSci Capital as an advisor to assist in implementing the related strategy. Processa stated that it will explore the use of blockchain assets to support its clinical development projects, strictly adhering to regulatory standards.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
OpenAI: GPT-5 is now the new default setting for all users in ChatGPT
U.S. Stock Market Closes Mixed as Major Indexes Diverge
Zelensky: Three Priorities for Ending the Russia-Ukraine Conflict
Trending news
MoreCrypto prices
More
